IL-37 Suppresses MyD88-mediated Inflammatory Responses in Human Aortic Valve Interstitial Cells
Tóm tắt
Calcific aortic valve disease (CAVD) is common among the elderly, and aortic valve interstitial cells (AVICs) exhibit unique inflammatory and osteogenic responses to proinflammatory stimulation, which plays an important role in valvular fibrosis and calcification. Thus, suppression of AVIC proinflammatory response may have therapeutic utility for the prevention of CAVD progression. Interleukin (IL)-37, an antiinflammatory cytokine, reduces tissue inflammation. This study aimed to test the hypothesis that IL-37 suppresses human AVIC inflammatory responses to Toll-like receptor (TLR) agonists. Human AVICs were exposed to Pam3CSK4, poly(I:C) and lipopolysaccharide in the presence and absence of recombinant human IL-37. Stimulation of TLR4 increased the production of intercellular adhesion molecule-1, IL-6, IL-8 and monocyte chemoattractant protein-1. Knockdown of myeloid differentiation factor 88 (MyD88) or TIR-domain-containing adaptor-inducing interferon-β differentially affected inflammatory mediator production following TLR4 stimulation. IL-37 reduced production of these inflammatory mediators induced by TLR4. Moreover, knockdown of IL-37 enhanced induction of these mediators by TLR4. IL-37 also suppressed inflammatory mediator production induced by the MyD88-dependent TLR2, but had no effect on the inflammatory responses to the TRIF-dependent TLR3. Furthermore, IL-37 inhibited NF-κB activation induced by TLR2 or TLR4 through a mechanism dependent of IL-18 receptor α-chain. Activation of TLR2, TLR3 or TLR4 upregulates the production of inflammatory mediators in human AVICs. IL-37 suppresses MyD88-mediated responses to reduce inflammatory mediator production following stimulation of TLR2 and TLR4. This antiinflammatory cytokine may be useful for suppression of aortic valve inflammation elicited by MyD88-dependent TLR signaling.
Tài liệu tham khảo
Go AS, et al. (2013) Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 127: e6–e245.
Hutcheson JD, Aikawa E, Merryman WD. (2014) Potential drug targets for calcific aortic valve disease. Nat. Rev. Cardiol. 11:218–31.
Rajamannan NM, et al. (2011) Calcific Aortic Valve Disease: Not Simply a Degenerative Process. A Review and Agenda for Research From the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive Summary: Calcific Aortic Valve Disease-2011 Update. Circulation. 124:1783–91.
Miller JD, Weiss RM, Heistad DD. (2011) Calcific aortic valve stenosis: methods, models, and mechanisms. Circ. Res. 108:1392–1412.
Boström KI, Rajamannan NM, Towler DA. (2011) The regulation of valvular and vascular sclerosis by osteogenic morphogens. Circ. Res. 109:564–77.
Dweck MR, et al. (2012) Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis. Circulation. 125:76–86.
Hjortnaes J, et al. (2010) Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation. Eur. Heart J. 31:1975–84.
Aikawa E, et al. (2007) Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation. 115:377–86.
Weiss RM, Miller JD, Heistad DD. (2013) Fibrocalcific Aortic Valve Disease: Opportunity to Understand Disease Mechanisms Using Mouse Models. Circ. Res. 113:209–22.
Alexopoulos A, et al. (2010) Bone regulatory factors NFATc1 and Osterix in human calcific aortic valves. Int. J. Cardiol. 139:142–9.
Rabkin-Aikawa E, Farber M, Aikawa M, Schoen FJ. (2004) Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. J. Heart Valve Dis. 13:841–7.
Meng X, et al. (2008) Expression of functional Toll-like receptors 2 and 4 in human aortic valve interstitial cells: potential roles in aortic valve inflammation and stenosis. Am. J. Physiol. Cell Physiol. 294: C29–C35.
Song R, et al. (2012) Biglycan induces the expression of osteogenic factors in human aortic valve interstitial cells via Toll-like receptor-2. Arterioscler. Thromb. Vasc. Biol. 32:2711–20.
Akira S, Takeda K. (2004) Toll-like receptor signalling. Nat. Rev. Immunol. 4:499–511.
Piccinini A, Midwood K. (2010) DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010:672395.
Akira S, Uematsu S, Takeuchi O. (2006) Pathogen recognition and innate immunity. Cell. 124:783–801.
Kaisho T, Akira S. (2006) Toll-like receptor function and signaling. J. Allergy Clin. Immunol. 117:979–87.
Fang Y, Hu J. (2011) Toll-like receptor and its roles in myocardial ischemic/reperfusion injury. Med. Sci. Monit. 17: RA100–09.
Björkbacka H. (2006) Multiple roles of Toll-like receptor signaling in atherosclerosis. Curr. Opin. Lipidol. 17:527–33.
Zeng Q, et al. (2013) Notch1 promotes the pro-osteogenic response of human aortic valve interstitial cells via modulation of ERK1/2 and nuclear factor-κB activation. Arterioscler. Thromb. Vasc. Biol. 33:1580–90.
Dinarello CA, et al. (2016) Suppression of innate inflammation and immunity by interleukin-37. Eur. J. Immunol. 46:1067–81.
Boraschi D, et al. (2011) IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur. Cytokine Netw. 22:127–47.
Zeng Q, et al. (2017) Interleukin-37 suppresses the osteogenic responses of human aortic valve interstitial cells in vitro and alleviates valve lesions in mice. Proc. Natl. Acad. Sci. USA. 114:1631–6.
Messier RH, et al. (1994) Dual structural and functional phenotypes of the porcine aortic valve interstitial population: characteristics of the leaflet myofibroblast. J. Surg. Res. 57:1–21.
Pimentel MM, Fuck RA. (1992) Neoproterozoic crustal accretion in central Brazil. Geology. 20:375–9.
Nold-Petry CA, et al. (2015) IL-37 requires the receptors IL-18R [alpha] and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction. Nat. Immunol. 16:354–65.
Mohler ER, et al. (2001) Bone formation and inflammation in cardiac valves. Circulation. 103:1522–28.
New SE, Aikawa E. (2011) Cardiovascular calcification: an inflammatory disease. Circ. J. 75:1305–13.
Yang X, Fullerton DA, Su X, Ao L, Meng X. (2009) Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of Toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2. J. Am. Coll. Cardiol. 53:491–500.
Zeng Q, et al. (2014) Augmented osteogenic responses in human aortic valve cells exposed to oxLDL and TLR4 agonist: a mechanistic role of Notch1 and NF-κB interaction. PLoS One. 9: e95400.
Zeng Q, et al. (2012) Cross-talk between the tolllike receptor 4 and notch1 pathways augments the inflammatory response in the interstitial cells of stenotic human aortic valves. Circulation. 126: S222–30.
Yamamoto M, et al. (2003) Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science. 301:640–3.
Takeda K, Akira S. (2004) TLR signaling pathways. Semin. Immunol. 16:3–9.
Schober A. (2008) Chemokines in vascular dysfunction and remodeling. Arterioscler. Thromb. Vasc. Biol. 28:1950–9.
Galkina E, Ley K. (2007) Vascular adhesion molecules in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27:2292–2301.
El Husseini D, et al. (2014) P2Y2 receptor represses IL-6 expression by valve interstitial cells through Akt: implication for calcific aortic valve disease. J. Mol. Cell. Cardiol. 72:146–56.
Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O’Brien KD. (1994) Characterization of the early lesion of ‘degenerative’ valvular aortic stenosis. Histological and immunohistochemical studies. Circulation. 90:844–53.
Akira S. (2000) Toll-like receptors: lessons from knockout mice. Biochem. Soc. Trans. 28:551–56.
Kawai T, Akira S. (2007) TLR signaling. Semin. Immunol. 19:24–32.
Alexopoulou L, Holt A, Medzhitov R, Flavell R. (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 413:732–8.
Zhan Q, et al. (2015) Activation of TLR3 induces osteogenic responses in human aortic valve interstitial cells through the NF-κB and ERK1/2 pathways. Int. J. Biol. Sci. 11:482.
López J, et al. (2012) Viral and bacterial patterns induce TLR-mediated sustained inflammation and calcification in aortic valve interstitial cells. Int. J. Cardiol. 158:18–25.
Zhan Q, et al. (2017) Double-stranded RNA up-regulates the expression of inflammatory mediators in human aortic valve cells through the TLR3-TRIF-non-canonical NF-κB pathway. Am. J. Physiol. Cell Physiol. 312:C407–17.